PharmacoPlatform: ICH E2B(R3) ICSR Gateways, Disproportionality Scoring & Real-World Safety Signal Mining

PharmacoPlatform delivers enterprise pharmacovigilance (PV) software architectures, automating Individual Case Safety Report (ICSR) intake, NLP-driven medical adverse event extraction from spontaneous reports and social media, and disproportionality signal detection under FDA FAERS and EMA EudraVigilance standards.

PharmacoPlatform Global Pharmacovigilance & Signal Detection Pipeline

Multichannel safety intake, MedDRA NLP normalization, and disproportionality scoring

Central System: Pharmacovigilance Core - E2B(R3) Engine & Disproportionality Analyzer

Clinical IoMT Nodes

  • Multichannel Safety Intake Sink
  • Clinical NLP / MedDRA Auto-Coder
  • Individual Case Safety Report (ICSR) Core
  • Disproportionality Signal Engine
  • Regulatory Gateway Dispatcher

Architectural Layers & Regulatory Standards

  • Multisource Adverse Event Ingestion (Optical Character Recognition (OCR) / Multi-Tenant Intake APIs): Ingesting adverse event reports from clinical trials, spontaneous patient hotlines, scientific literature, and social platforms.
  • Medical Ontology Normalization (Clinical Transformer Models / MedDRA Dictionary v26+): Mapping unstructured patient symptom descriptions into standardized Medical Dictionary for Regulatory Activities (MedDRA) terms.
  • Statistical Signal Detection & Disproportionality (Bayesian Confidence Propagation Neural Network (BCPNN)): Computing Proportional Reporting Ratios (PRR) and empirical Bayes geometric means to detect emerging safety signals.
  • Automated Regulatory Electronic Submission (AS2 Secure Gateway / E2B(R3) XML Validator): Validating and transmitting expedited 7-day and 15-day safety reports to FDA FAERS and EudraVigilance.

Key Metrics: < 15 min (Automated ICSR Processing Time) | 99.4% (MedDRA Coding Accuracy) | 100% (ICH E2B(R3) XML Schema Compliance) | Real-Time (Adverse Signal Disproportionality Mining)

Automated Pharmacovigilance, E2B(R3) Safety Reporting & Adverse Drug Reaction (ADR) Signal Detection

Authoritative technical engineering reference for automated pharmacovigilance, e2b(r3) safety reporting & adverse drug reaction (adr) signal detection in FDA Premarket submissions, EU MDR, IEC 62304 Class C software lifecycle, ISO 13485 quality systems, and IoMT zero-trust interoperability.

Core Engineering Areas

Technical Articles

Related Cluster Architecture Specifications